The global cardiac arrest treatment market is expected to grow significantly at a CAGR of 5.4% during the forecasted period (2021 to 2027). The main causes of cardiac arrest are an inactive lifestyle, obesity, diabetes mellitus, smoking, high cholesterol, and high blood pressure. Demand for cardiac arrest treatment is anticipated to increases as the number of persons suffering from these illnesses are increases. 

Cardiac arrest is caused by an electrical disruption in the heart as a result of the signal malfunction. A sudden loss of heart function, awareness, and agonal breathing is referred to as cardiac arrest. Cardiac arrest occurs more frequently in the elderly and those with coronary artery disease. As a result, the growing elderly population is generating remarkable market growth.

Another major factor is the advancement of modern cardiovascular instruments to save patients' lives that will propel the market forward during the anticipated period. Inactive lifestyles, obesity, and high cholesterol levels in the majority of developed and emerging countries are estimated to provide future market growth prospects. However, during the projection period, factors such as stringent regulations for employing medical tools required for the treatment of cardiac arrest are expected to obstruct market expansion.

Market Coverage: 

• The market number available for – 2021-2027
• The base year – 2020 
• The forecast period is from 2021 to 2027
• Segment Covered- 

o By  type

o By service providers

• Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: ZOLL Medical Corp., General Electric Co., Abbott Laboratories, Stryker Corp., Boston Scientific Corp., and Koninklijke Philips N.V.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cardiac Arrest Treatment Market by Segment

By Treatment

• Drugs
• Vasopressors
• Corticosteroid
• Anti-arrhythmic Drugs
• Others (Beta-blockers and Fibrinolytic drugs)
• Medical Devices
• Defibrillator
• Cardiac Resynchronization Therapy
• Others (Ventricular Assist Devices)

Global Cardiac arrest market by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa